Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$4.84
0.439.75%
Últ. Act.: Oct 28, 4:46 PM
Market sentiment signals for Entrada Therapeutics (TRDA): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Outperform
5 analysts
Options Flow (P/C)
—
Avg Consensus PT
$23
+382.3%
Highest Price Target
$29
+514.8%
Lowest Price Target
$17
+260.4%
Short Interest
11.9%
Rising — Bearish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Jun 8, 2026 | Guggenheim | Debjit Chattopadhyay— | +260.4% | $20 → $17 | Maintained | Buy |
| May 8, 2026 | HC Wainwright & Co. | Raghuram Selvaraju— | — | — | Downgrade | Buy→Neutral |
